Multidimensional phenotyping of human stem cell-derived midbrain dopaminergic neurons from a SNCA triplication carrier for drug screening applications
Objective: We hypothesized that combining multiple Parkinson's disease (PD) relevant cellular phenotypes will increase the accuracy, stability, and usability of human midbrain dopaminergic (mDA) neuronal…Subclinical cognitive patterns of caudate-anchored connectivity in early Parkinson’s disease
Objective: This study is aimed at elucidating the changes of cognitive connectivity according to orthostatic stress in early Parkinson’s disease (PD). Background: 18F-Florbetaben tracer can…Resequencing of the complete SNCA locus in Indian patients with Parkinson’s disease
Objective: To perform targeted resequencing of the SNCA locus to identify novel variants in the Indian patients with Parkinsons’s disease (PD). Background: To date, most…Statin use and incidence of Parkinson’s disease in women from the French E3N cohort study
Objective: To examine whether incident statin use is associated with lower Parkinson’s disease (PD) incidence while considering the potential for reverse causation. Background: Drug repurposing…Association between income and hospital length of stay in Parkinson Disease: a nationwide cross-sectional analysis
Objective: To investigate the relationship between income and hospital length of stay (LOS) and discharge disposition in a Parkinson Disease (PD) cohort admitted to the…Time reproduction in Parkinson’s disease: Is there a specific impairment in context of movements?
Objective: Investigating the reproduction of time intervals in context of a motor imagery task in Parkinson’s disease Background: In Parkinson’s disease (PD), impaired perception of…OPICAPONE ADD-ON THERAPY IN LEVODOPA-CARBIDOPA INTESTINAL GEL INFUSION: which patient might benefit the most?
Objective: To explore the benefit of Opicapone (OPC) add-on to levodopa-carbidopa intestinal gel (LCIG) in different phenotypes of Parkinson’s Disease (PD) patients. Background: LCIG monotherapy…Defining nomenclature and age cut off for Early Onset Parkinson’s Disease: Recommendations from the Early Onset Parkinson’s Disease Task Force.
Objective: To define the nomenclature for Early Onset Parkinson Disease (EOPD) / Young Onset Parkinson Disease (YOPD), and the age at onset (AAO) cut off…A lower rate of hyposmia in non-Ashkenazi jewish patients with Parkinson’s disease: motor and non-motor disease characteristics in different ethnic groups in Israel
Objective: We aim to describe clinical aspects of Parkinson's disease (PD) in different ethnic groups in Israel, focusing on Non-Ashkenzi Jews (NAJ) ethnic groups vs.…Parkinson’s disease caregiver burden in rural India
Objective: To assess the caregiver burden and factors determining it in patients with PD. To assess the anxiety and depression amongst caregivers. Background: Patients with…
- « Previous Page
- 1
- …
- 251
- 252
- 253
- 254
- 255
- …
- 338
- Next Page »